Sign in
4

Changes in Ownership

CORCEPT THERAPEUTICS INC Filed Acc 0000950170-23-068368

Chief Development Officer acquired 1,218 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Guyer William Chief Development Officer 2023-12-01 Grant or award +609 $25.97 $15,816 6,034 D
Guyer William Chief Development Officer 2023-12-01 Grant or award +609 6,643 D
Loading xslF345X05/ownership.xml…